- Clinical Trials
- August 2024
- 60 Pages
Global
From €1142EUR$1,250USD£976GBP
- Report
- June 2024
- 200 Pages
Global
From €7261EUR$7,950USD£6,209GBP
- Report
- January 2022
- 60 Pages
Global
From €3608EUR$3,950USD£3,085GBP
- Report
- August 2023
- 250 Pages
Global
From €3261EUR$3,570USD£2,788GBP
The Typhoid Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Typhoid drugs are specifically used to treat typhoid fever, a bacterial infection caused by the Salmonella typhi bacteria. Treatment typically involves antibiotics, such as ampicillin, chloramphenicol, and ciprofloxacin. Vaccines are also available to prevent typhoid fever.
The Typhoid Drug market is highly competitive, with a number of companies offering products. These include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Other companies, such as Bharat Biotech, have recently entered the market with new vaccines. Show Less Read more